Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCastelnau Group Regulatory News (CGL)

Share Price Information for Castelnau Group (CGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 78.50
Bid: 77.00
Ask: 80.00
Change: 0.00 (0.00%)
Spread: 3.00 (3.896%)
Open: 78.50
High: 78.50
Low: 78.50
Prev. Close: 78.50
CGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Castelnau Group Limited

16 Jan 2023 10:26

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Talisman Strategic Fund, Ltd.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Castelnau Group Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12 January 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Ord NPV

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,000,000

2.71

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

5,000,000

2.71

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

N/A

N/A

N/A

N/A

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

N/A

N/A

N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

 

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

16 January 2023

Contact name:

Marius Raath

Telephone number*:

020 7647 4600

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230113005343/en/

Copyright Business Wire 2023

Date   Source Headline
1st Mar 20132:33 pmRNSTotal Voting Rights
22nd Feb 20132:51 pmRNSHolding(s) in Company
13th Feb 20132:47 pmRNSDirector/PDMR Shareholding
8th Feb 20139:00 amRNSDividend Declaration
8th Feb 20137:00 amRNSAnnual Financial Report
1st Feb 201312:28 pmRNSTotal Voting Rights
2nd Jan 201312:19 pmRNSBlocklisting Interim Review
2nd Jan 201312:17 pmRNSBlocklisting Interim Review
2nd Jan 201312:14 pmRNSTotal Voting Rights
21st Dec 20124:51 pmRNSDirector/PDMR Shareholding
21st Dec 20124:30 pmRNSDirector/PDMR Shareholding
18th Dec 20127:00 amRNSSandy storm estimates
3rd Dec 201212:14 pmRNSTotal Voting Rights
22nd Nov 20128:00 amRNSNew Group Claims Director
22nd Nov 20128:00 amRNSInvestor Day
12th Nov 20127:00 amRNSInterim Management Statement
1st Nov 20124:05 pmRNSTotal Voting Rights
8th Oct 20124:04 pmRNSDirector/PDMR Shareholding
1st Oct 20122:56 pmRNSTotal Voting Rights
25th Sep 201212:00 pmRNSFinancial Calendar
7th Sep 201212:25 pmRNSDirector/PDMR Shareholding
3rd Sep 20122:38 pmRNSTotal Voting Rights
7th Aug 20122:48 pmRNSDirector/PDMR Shareholding
6th Aug 201211:09 amRNSDirector Declaration
6th Aug 20129:59 amRNSDividend Declaration
6th Aug 20127:00 amRNSHalf Yearly Report
1st Aug 201210:49 amRNSTotal Voting Rights
3rd Jul 20127:00 amRNSTotal Voting Rights
2nd Jul 20122:56 pmRNSBlocklisting Interim Review
2nd Jul 20122:54 pmRNSBlocklisting Interim Review
28th Jun 20124:31 pmRNSDirector/PDMR Shareholding
7th Jun 20122:12 pmRNSDirector/PDMR Shareholding
1st Jun 201210:52 amRNSTotal Voting Rights
11th May 20127:00 amRNSInterim Management Statement
1st May 20124:03 pmRNSTotal Voting Rights
12th Apr 201212:08 pmRNSHolding(s) in Company
10th Apr 201212:21 pmRNSAnnual Information Update
2nd Apr 20124:23 pmRNSDirector/PDMR Shareholding
2nd Apr 20124:21 pmRNSTotal Voting Rights
16th Mar 20122:28 pmRNSAnnual Financial Report
13th Mar 20122:29 pmRNSDirector/PDMR Shareholding
1st Mar 20124:19 pmRNSTotal Voting Rights
21st Feb 20123:00 pmRNSDirector/PDMR Shareholding
16th Feb 20124:21 pmRNSDirector/PDMR Shareholding
15th Feb 20125:15 pmRNSDirector/PDMR Shareholding
13th Feb 20123:09 pmRNSDirector/PDMR Shareholding
13th Feb 20123:03 pmRNSDirector/PDMR Shareholding
9th Feb 20129:00 amRNSDividend Declaration
9th Feb 20127:00 amRNSFinal Results
1st Feb 20123:59 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.